The Ticker

A look back at the past week on Wall Street

What’s hot

The market got a charge out of Gillette’s decision to purchase Duracell International.

The shaving giant announced this week it was paying the famous buyout firm Kohlberg Kravis Roberts more than $58 a share for the battery company in a $7 billion deal. KKR had purchased Duracell from Kraft in 1988 for $1.8 billion. Duracell ended the week at $62.37-1/2, up more than $13 since Thursday, while Gillette finished at $70.37-1/2. … Heartstream received FDA approval this week to market its ForeRunner defibrilator, the first in a new wave of smaller, cheaper devices to restart hearts. The news jolted the Seattle-based company’s stock, jumping it from $11.25 to $15.43-3/4 in two days. … If you’re looking for a winner, it might be Oracle Corp. The company’s shares rose as much as 12 percent this week as analysts recommended that investors look past lackluster earnings and buy shares in the fast-growing database computer software maker. Redwood City, Calif.-based Oracle closed Friday at $42, up $4.50.

What’s not

Rykoff-Sexton, Inc. announced late Thursday that its profits would stay flat or fall this quarter. The stock didn’t stay flat Friday, it fell, dropping $1.12-1/2 to close the week at $13.87-1/2.